Kamath C R, Maruyama Y, DeLand F H, Van Nagell J R
Gynecol Oncol. 1983 Apr;15(2):171-85. doi: 10.1016/0090-8258(83)90072-0.
The value of X-ray studies and bone scan studies of cervix cancer patients was evaluated by a review of patient charts and bone scans or X-ray studies. No in situ cancer patients had positive studies. A low frequency of positive X-ray studies was observed ranging from 1% with stage I to 10% with stage IV disease. Recurrent carcinoma had 10% positive studies. Bone scans correlated well with positive X-ray studies but 10% false-positive scans were seen, mostly osteoarthritis. The bone scan was much more sensitive and appeared to detect an earlier stage lesion, usually associated with symptoms which with radiation and other treatments could follow a more indolent course than the patient with a positive X-ray study. The present study evaluates the appearance and value of these studies, the frequency and circumstances under which useful information was obtained, and what type of survival followed the establishment of the diagnosis.
通过查阅患者病历以及骨扫描或X线检查结果，对宫颈癌患者的X线检查和骨扫描检查的价值进行了评估。原位癌患者的检查结果均为阴性。X线检查阳性率较低，I期患者为1%，IV期患者为10%。复发性癌的检查阳性率为10%。骨扫描与X线检查阳性结果相关性良好，但发现有10%的扫描结果为假阳性，主要是骨关节炎。骨扫描更为敏感，似乎能检测到更早阶段的病变，通常伴有一些症状，与X线检查阳性的患者相比，接受放疗和其他治疗后，其病程可能更为缓慢。本研究评估了这些检查的表现和价值、获得有用信息的频率和情况，以及确诊后的生存类型。
